Compounds useful as reversible inhibitors of cysteine proteases
Disclosed are cathepsin S, K, F, L and B reversible inhibitory compounds of the formulas (I), (II), (Ia) and (Ib) further defined herein. The compounds are useful for treating autoimmune diseases. Also disclosed are processes for making such novel compounds
Boehringer Ingelheim Pharmaceuticals Inc.
A C A A C C C C C A C A C C C A C A C C C C C A C A A A C
A61P C07D A61P A61P C07D C07D C04B C07D C07D A61P C07D A61P C07D C07D C07D A61P C07D A61P C07D C07D C07D C07D C07D A61P C07D A61P A61P A61P C07D
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Tina Marie David S. Leah L. Yancey David Eugene R. Weimin Denice Mary Erick Richard Roush Michel Jose
Morwick Thomson Frye Ward Hickey Liu Spero Young Emmanuel